Adherium (ASX:ADRDB) Quality Rank


ASX:ADRDB Adherium Ltd ASX:ADRDB
8 GF Score
Price A$0.20
GF Value A$0.35
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is Adherium Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Adherium Quality Rank Related Terms

ASX:ADRDB
8GF Score
Adherium Ltd ASX:ADRDB
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Adherium (ASX:ADRDB) Overvalued in 2026?

Based on GuruFocus' analysis, Adherium stock appears to be undervalued. The current stock price of A$0.20 is trading 42.9% below its estimated GF Value™ of A$0.35. GuruFocus considers Adherium to be Possible Value Trap.

Key valuation signals for ASX:ADRDB:

  • Quality Rank:
  • GF Value™: A$0.35 vs. price of A$0.20 (42.9% below fair value)
  • GF Score™: 8/100 with 8 warning signs

No single metric tells the full story. See the ASX:ADRDB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Adherium Business Description

Other Exchanges ADRMF:USA
Address 447 Collins Street, Level 5, Melbourne, VIC, AUS, 3000
Adherium Ltd is engaged in the development, manufacture, and supply of its Hailie digital health technologies that address sub-optimal medication use and improve health outcomes in chronic disease. It is an international Respiratory eHealth company focused on patient medication adherence, remote monitoring, and data management solutions for patients, payers, and providers. Its geographically segments include New Zealand and Australia, Europe, North America, and Asia. The majority of its revenue comes from Europe.
8GF Score

Get the complete analysis for ASX:ADRDB

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.20
Price
A$0.35
GF Value